Elevated Intraluminal Pressure Inhibits Vascular Tissue Plasminogen Activator Secretion and Downregulates Its Gene Expression
- 1 April 2000
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 35 (4) , 1002-1008
- https://doi.org/10.1161/01.hyp.35.4.1002
Abstract
—We recently discovered that patients with essential hypertension have a markedly impaired capacity for stimulated release of tissue plasminogen activator (tPA) from vascular endothelium. This defect may reduce the chance of timely spontaneous thrombolysis in case of an atherothrombotic event. We now investigated whether increased intraluminal pressure as such may depress vascular tPA release or downregulate its gene expression. Segments of human umbilical veins were studied in a new computerized vascular perfusion model under steady laminar flow conditions for 3 or 6 hours. Paired segments were perfused at high or physiological intraluminal pressure (40 versus 20 mm Hg) under identical shear stress (10 dyne/cm 2 ). Quantitative immunohistochemical evaluation of cellular tPA immunoreactivity was performed on paraffin-embedded 5-μm vascular sections. tPA mRNA in endothelial cells was quantified with reverse transcription real-time TaqMan polymerase chain reaction with GAPDH as endogenous control. Secretion of tPA into perfusion medium was evaluated with SDS-PAGE and Western blotting, followed by densitometric quantification. High-pressure perfusion downregulated tPA gene expression with a 38% decrease in tPA mRNA levels ( P =0.01) compared with vessels perfused under normal intraluminal pressure. tPA release into the perfusion medium was markedly suppressed by high pressure ( P <0.01 ANOVA). The intracellular storage pool of tPA was reduced after 6 but not 3 hours. Thus, elevated intraluminal pressure downregulates tPA gene and protein expression and inhibits its release from the endothelium independently of shear stress. The defective capacity for stimulated tPA release that we demonstrated in patients with essential hypertension might thus be an effect of the elevated intraluminal pressure per se.Keywords
This publication has 18 references indexed in Scilit:
- A New Computerized Biomechanical Perfusion Model for ex vivo Study of Fluid Mechanical Forces in Intact Conduit VesselsJournal of Vascular Research, 1999
- Impaired capacity for endogenous fibrinolysis in essential hypertensionThe Lancet, 1998
- Regulation of the Acute Release of Tissue‐type Plasminogen Activator from the Endothelium by Coagulation Activation ProductsAnnals of the New York Academy of Sciences, 1992
- Cyclical strain effects on production of vasoactive materials in cultured endothelial cellsJournal of Cellular Physiology, 1992
- Stimulation of endothelial secretion of tissue-type plasminogen activator by repetitive stretchJournal of Surgical Research, 1991
- Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stressJournal of Cellular Physiology, 1990
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Fluid Flow Stimulates Tissue Plasminogen Activator Secretion by Cultured Human Endothelial CellsScience, 1989
- Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983